BIOX Earning Date, Earning Analysis and Earning Prediction

Quarterly Results

BIOX Earnings Forecast

Looking ahead, BIOX remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2026/Q3 project quarter revenue of 60.27M and an EPS of -0.09.

However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2026 have been unchanged by 0%, while EPS estimates have been unchanged by 0%. For the upcoming Q2 2026, revenue estimates have been adjusted unchanged by 0%. These revisions correlate with a -14.25% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in BIOX long-term fundamentals.

The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.

RevenueEPS

Currency: USD

Revenue Estimate-:0

EPS Estimate-:0

—

Stock Price0

Revenue Estimates for FY2026

No Change

0.00%

In Past 3 Month

EPS Estimates for FY2026

No Change

0.00%

In Past 3 Month

Revenue Estimates for Q2 2026

No Change

0.00%

In Past 3 Month

Stock Price

Go Down

-14.25%

In Past 3 Month

Earnings Forecast

Revenue

EPS

Currency: USD

Actual

Estimate

AI Analysis

Earnings Surprise Analysis

Revenue

EPS

AI Analysis

Earnings Reaction

The chart below shows how BIOX performed 10 days before and after its earnings report, based on data from the past quarters. Typically, BIOX sees a 11.23% change in stock price 10 days leading up to the earnings, and a -2.72% change 10 days following the report. On the earnings day itself, the stock moves by -4.5%. This data can give you a slight idea of what to expect for the next quarter's release.

For example, in MAR/2026, the stock changed -9.33% on the day following the earnings release and then changed by -7.54% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.

People Also Watch

Frequently Asked Questions

What were the key highlights of BIOX's latest earnings report for ?

BIOX reported its earnings on 2026-05-12, showcasing a revenue of against an estimate of 54.50M, resulting in a 0% surprise. The EPS was 0, surpassing the expected -0.05 by 0%. The stock experienced a -16.94% price change on the earnings day and a -20.99% change over the next five days, reflecting market reactions to the results.

How did BIOX's stock price react after the earnings release?

Following BIOX's earnings announcement on 2026-05-12, the stock price moved by -16.94% on the day of the release. Over the subsequent five days, it saw a -20.99% change. Historically, BIOX's stock price tends to shift by an average of 11.23% in the 10 days leading up to earnings and -2.72% in the 10 days following, providing insight into potential market.

What are the revenue and EPS estimates for BIOX for 2026/Q3?

For 2026/Q3, analysts estimate BIOX's annual revenue to reach 60.27M, while the EPS is projected at -0.09. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

How does BIOX's stock price correlate with earnings forecast revisions?

The correlation between BIOX's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2026 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

What should investors expect from BIOX's next earnings report?

Based on historical trends, BIOX's stock price typically moves by 11.23% in the 10 days before its earnings and -2.72% in the 10 days after. For the upcoming 2026/Q3 earnings, analysts expect an EPS of -0.09 and revenue of 60.27M.

What is the sentiment in Bioceres Crop Solutions Corp (BIOX) Q3 2026 Earnings Call Summary?

The earnings call reveals significant financial challenges, including a 23% revenue decline, negative EBITDA, and high debt with liquidity concerns. Market conditions remain tough, with competitive pressures and inventory issues. The strategic shift has led to a sharp decline in Seeds revenue. Legal risks and uncertain outcomes add to the uncertainty. The Q&A session showed management's evasiveness on cash flow details, further raising concerns. Overall, these factors indicate a strong negative sentiment, likely leading to a stock price decline.